Shareholders approve 16M share increase in equity plan at Pacific Biosciences annual meeting

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Stockholders approved amendment to 2020 Equity Incentive Plan, adding 16,000,000 shares for future grants.
Four Class III directors elected: Ericson, Ordoñez, Smith, Gibson, Henry, Milligan.
Ernst & Young ratified as independent registered public accounting firm for FY2026.
Advisory say-on-pay proposal approved with 114,050,930 votes for, 21,239,989 against.
Annual meeting had ~65% of shares represented (203,009,375 of 310,487,099 outstanding).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Election of Four Class III Directors at the 2026-06-03 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 1: Election of Four Class III Directors Name of Director For Against Abstain Broker Non-Votes William Ericson 128,010,323 8,109,601 1,111,140 65,778,311 Kathy Ordoñez 130,522,400 5,673,816 1,034,848 65,778,311 Christopher M. Smith 131,731,235 4,069,337 1,430,492 65,778,311 Chris Gibson, Ph.D. 131,899,750 4,107,270 1,224,044 65,778,311 Christian O. Henry 129,999,918 5,924,115 1,307,031 65,778,311 John F. Milligan, Ph.D. 130,471,635 5,650,906 1,108,523 65,778,311 Each director nominee was duly elected

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 198,046,666 3,990,483 972,226 — The stockholders ratified the appointment of Ernst & Young LLP

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Advisory Vote on Approval of Named Executive Officer Compensation at the 2026-06-03 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation For Against Abstain Broker Non-Votes 114,050,930 21,239,989 1,940,145 65,778,311 The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Approval of Amendment to the 2020 Equity Incentive Plan at the 2026-06-03 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan For Against Abstain Broker Non-Votes 114,865,820 20,469,132 1,896,112 65,778,311 The stockholders approved the amendment to the 2020 Plan

View on SEC.gov

404 shareholder votes filed in the last 30 days. Browse all shareholder votes →

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filing history →

Source: SEC EDGAR

accession 0001299130-26-000092

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.